[go: up one dir, main page]

WO2007110884A3 - A process for the preparation of highly pure anhydrous fexofenadine hydrochloride - Google Patents

A process for the preparation of highly pure anhydrous fexofenadine hydrochloride Download PDF

Info

Publication number
WO2007110884A3
WO2007110884A3 PCT/IN2007/000127 IN2007000127W WO2007110884A3 WO 2007110884 A3 WO2007110884 A3 WO 2007110884A3 IN 2007000127 W IN2007000127 W IN 2007000127W WO 2007110884 A3 WO2007110884 A3 WO 2007110884A3
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
highly pure
fexofenadine hydrochloride
pure anhydrous
anhydrous fexofenadine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2007/000127
Other languages
French (fr)
Other versions
WO2007110884A2 (en
Inventor
Lilit Wadhwa
Satyendra Pal Singh
Gajendra Singh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ind Swift Laboratories Ltd
Original Assignee
Ind Swift Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ind Swift Laboratories Ltd filed Critical Ind Swift Laboratories Ltd
Publication of WO2007110884A2 publication Critical patent/WO2007110884A2/en
Anticipated expiration legal-status Critical
Publication of WO2007110884A3 publication Critical patent/WO2007110884A3/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a novel and industrially advantageous process for the preparation of highly pure anhydrous Fexofenadine hydrochloride directly from fexofenadine base without isolating hydrous Fexofenadine hydrochloride.
PCT/IN2007/000127 2006-03-29 2007-03-28 A process for the preparation of highly pure anhydrous fexofenadine hydrochloride Ceased WO2007110884A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN873/DEL/2006 2006-03-29
IN873DE2006 2006-03-29

Publications (2)

Publication Number Publication Date
WO2007110884A2 WO2007110884A2 (en) 2007-10-04
WO2007110884A3 true WO2007110884A3 (en) 2009-05-28

Family

ID=38541539

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2007/000127 Ceased WO2007110884A2 (en) 2006-03-29 2007-03-28 A process for the preparation of highly pure anhydrous fexofenadine hydrochloride

Country Status (1)

Country Link
WO (1) WO2007110884A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012087100A (en) * 2010-10-21 2012-05-10 Sumitomo Chemical Co Ltd Method for producing fexofenadine monohydrochloride of form i
CN104072402B (en) * 2014-07-16 2016-08-17 昆山龙灯瑞迪制药有限公司 A kind of fexofenadine hydrochloride compound of new crystalline form and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002066429A1 (en) * 2001-02-23 2002-08-29 Cilag Ag Method for producing non-hydrated fexofenadine hydrochloride and a novel crystalline form obtained thereby
US20040004038A1 (en) * 2002-07-03 2004-01-08 Jfe Engineering Corporation Method and apparatus for treating sludge, and method and apparatus for treating wastewater utilizing the same
WO2005009175A2 (en) * 2003-05-29 2005-02-03 Star Cushion Products, Inc. Methods for fabricating cellular cushions

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002066429A1 (en) * 2001-02-23 2002-08-29 Cilag Ag Method for producing non-hydrated fexofenadine hydrochloride and a novel crystalline form obtained thereby
US20040004038A1 (en) * 2002-07-03 2004-01-08 Jfe Engineering Corporation Method and apparatus for treating sludge, and method and apparatus for treating wastewater utilizing the same
WO2005009175A2 (en) * 2003-05-29 2005-02-03 Star Cushion Products, Inc. Methods for fabricating cellular cushions

Also Published As

Publication number Publication date
WO2007110884A2 (en) 2007-10-04

Similar Documents

Publication Publication Date Title
EP2460797A3 (en) Process for preparation of ivabradine hydrochloride
IL190551A0 (en) Novel process for the preparation of acid chlorides
TW200833657A (en) Novel process
WO2009139817A3 (en) Crystalline pharmaceutical and methods of preparation and use thereof
WO2011015522A3 (en) Process for the manufacture of pharmaceutically active compounds
WO2010062590A3 (en) Process for the preparation of protected l-alanine derivatives
MY147732A (en) Process for the preparation of 2-substituted-5- (1-alkylthio) alkylpyridines
WO2006099468A3 (en) Process for the purification of duloxetine hydrochloride
WO2010060624A3 (en) Dry processing and novel forms of lacosamide
EP1613573A4 (en) Production of 5-methyl-1-hydrocarbyl-2-pyrrolidone by reductive amination of levulinic acid
MX2011007978A (en) Novel method for the synthesis of ivabradine and the pharmaceutically acceptable acid addition salts thereof.
WO2004014310A3 (en) Novel processes for the preparation of peripheral opioid antagonist compounds and intermediates thereto
ZA200900282B (en) An improved process for the preparation of sucralose of high purity
WO2010004578A3 (en) Novel and improved processes for the preparation of paliperidone
HUP0501167A3 (en) Process for industrial scale production of high purity donepezil hydrochloride polymorph i.
WO2010121877A3 (en) Process for the preparation of olopatadine
WO2010083996A8 (en) A process for preparing memantine
MX2012002818A (en) Novel method for synthesizing ivabradine and the addition salts thereof with a pharmaceutically acceptable acid.
EP1765761A4 (en) Novel analogs of 3-o-acetyl-11-keto-beta-boswellic acid
WO2007099552A3 (en) Novel crystalline form of atovastatin hemi-magnesium
IL188535A0 (en) Process for the preparation of highly pure 1-[2-dimethylamino-(4-methoxyphenyl)ethyl]cyclohexanol hydrochloride
WO2010119450A3 (en) An improved process for the preparation of desmopressin or its pharmaceutically acceptable salts
WO2011018771A3 (en) Process for the preparation of valganciclovir hydrochloride
WO2007110884A3 (en) A process for the preparation of highly pure anhydrous fexofenadine hydrochloride
TW200728310A (en) Process for the preparation of ferri-succinylcasein

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07736583

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07736583

Country of ref document: EP

Kind code of ref document: A2